Lycetamine

Lycetamine

SCHEMBL831216

CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)CCCCN.N=C(N)NCCCC(N)C(=O)O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACES1PR1S1PR4S1PR5

The experimentally established mechanism targets of Lycetamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
S1PR1 known ✓ P21453 2/20 0.43
S1PR5 known ✓ Q9H228 1/20 0.43
GNAI3 P08754 1/20 0.74
GNAO1 P09471 1/20 0.74
GNAI1 P63096 1/20 0.74
RRM1 P23921 1/20 0.61
DPP7 Q9UHL4 3/20 0.59
NOD1 Q9Y239 2/20 0.56
SIRT6 Q8N6T7 1/20 0.51
SIRT1 Q96EB6 1/20 0.51
GSR P00390 1/20 0.48
TLR2 O60603 6/20 0.47
S1PR2 O95136 2/20 0.43
S1PR3 Q99500 2/20 0.43
DPP8 Q6V1X1 1/20 0.43
DPP9 Q86TI2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octadecylamine SCHEMBL21055685 0.93 GNAI3 (0.59) GNAI3GNAO1GNAI1RRM1DPP7
Octadecylamine SCHEMBL21055684 0.93 GNAI3 (0.59) GNAI3GNAO1GNAI1RRM1DPP7
SCHEMBL24420660 0.89 DPP7 (0.73) GNAI3GNAO1GNAI1RRM1DPP7
SCHEMBL27115127 0.89 DPP7 (0.73) GNAI3GNAO1GNAI1RRM1DPP7
Lycetamine SCHEMBL15367599 0.87 GNAI3 (0.91) GNAI3GNAO1GNAI1RRM1DPP7
SCHEMBL19362563 0.87 GNAI3 (0.66) GNAI3GNAO1GNAI1RRM1DPP7
SCHEMBL6037849 0.87 DPP7 (0.53) GNAI3GNAO1GNAI1RRM1DPP7
SCHEMBL27114206 0.87 DPP7 (0.76) GNAI3GNAO1GNAI1RRM1DPP7
SCHEMBL6037862 0.87 DPP7 (0.53) GNAI3GNAO1GNAI1RRM1DPP7
Arginine SCHEMBL6242106 0.87 DPP7 (0.53) GNAI3GNAO1GNAI1RRM1DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143372-B2 Synthetic regulators of ferritin protein nanocage pores and methods of use thereof CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND (US) 2012-03-27 US disclosed
US-20090325869-A1 SYNTHETIC REGULATORS OF FERRITIN PROTEIN NANOCAGE PORES AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-12-31 US disclosed